Takeda Uk Limited

POWER SEARCH PRICING

SOLUTIONS

takeda uk limited Company Information

Company Number

03362860

Next Accounts

Dec 2025

Directors

Kentaro Shirahata

Peter Grubin

View All

Shareholders

takeda pharmaceuticals international ag

Group Structure

View All

Industry

Wholesale of pharmaceutical goods

Registered Address

1 kingdom street, london, W2 6BD

Website

www.takeda.co.uk

takeda uk limited Estimated Valuation

£447.4m

Pomanda estimates the enterprise value of TAKEDA UK LIMITED at £447.4m based on a Turnover of £516m and 0.87x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Takeda Uk Limited is a live company located in london, W2 6BD with a Companies House number of 03362860. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 1997, it's largest shareholder is takeda pharmaceuticals international ag with a 100% stake. Takeda Uk Limited is a mature, mega sized company, Pomanda has estimated its turnover at £516m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Takeda Uk Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating4out of 5

4 Strong

3 Regular

4 Weak

Size

annual sales of £516m, make it larger than the average company (£25.1m)

Growth

3 year (CAGR) sales growth of 30%, show it is growing at a faster rate (5.6%)

EXPORT

Takeda Uk Limited's latest turnover from March 2024 is £516 million and the company has net assets of £164.9 million. According to their latest financial statements, Takeda Uk Limited has 291 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	516,006,280	484,203,039	470,004,617	237,076,042	203,289,598	180,822,494	149,948,936	121,776,218	90,767,272	78,299,481	66,072,029	59,534,184	153,231,555	178,231,291	155,321,012
Other Income Or Grants
Cost Of Sales	403,169,003	404,831,148	377,760,534	198,390,566	154,637,071	140,531,079	124,766,938	95,839,880	66,017,504	54,261,919	44,931,196	39,357,418	116,367,310	140,875,581	91,989,321
Gross Profit	112,837,277	79,371,891	92,244,083	38,685,476	48,652,527	40,291,415	25,181,998	25,936,338	24,749,768	24,037,562	21,140,833	20,176,766	36,864,245	37,355,710	63,331,691
Admin Expenses	92,197,026	60,403,896	61,117,754	29,025,530	40,638,353	32,074,369	22,434,701	24,045,834	21,033,153	14,936,708	14,774,932	17,775,185	31,941,720	32,350,409	58,159,045
Operating Profit	20,640,251	18,967,995	31,126,329	9,659,946	8,014,174	8,217,046	2,747,297	1,890,504	3,716,615	9,100,854	6,365,901	2,401,581	4,922,525	5,005,301	5,172,646
Interest Payable	146,782	5,701	3,806,060	460,269	237,154	203,217	31,335	4,200	8,321	18,151	14,728	9,545
Interest Receivable	1,581,496	1,257,217	1,770,939	494,625	7,446	12,115	1,545	23,445	26,622	89,777	30,201	47,515	374,928	287,463	198,664
Pre-Tax Profit	22,074,965	20,219,511	29,381,861	9,694,302	7,784,466	8,025,944	2,744,629	1,957,019	3,658,112	9,686,477	2,823,162	2,410,229	5,135,062	5,214,758	5,357,848
Tax	-5,938,855	-1,704,399	-4,144,629	-1,909,624	-1,384,467	-1,412,716	-536,629	59,148	-778,628	-2,008,686	-1,378,509	-449,120	-1,720,577	3,427,659	140,130
Profit After Tax	16,136,110	18,515,112	25,237,232	7,784,678	6,399,999	6,613,228	2,208,000	2,016,167	2,879,484	7,677,791	1,444,653	1,961,109	3,414,485	8,642,417	5,497,978
Dividends Paid
Retained Profit	16,136,110	18,515,112	25,237,232	7,784,678	6,399,999	6,613,228	2,208,000	2,016,167	2,879,484	7,677,791	1,444,653	1,961,109	3,414,485	8,642,417	5,497,978
Employee Costs	35,732,393	34,530,627	36,775,313	22,693,839	23,859,440	21,235,218	17,508,188	15,840,221	8,583,521	9,095,093	8,741,649	5,132,902	4,841,769	4,796,252	4,062,766
Number Of Employees	291	277	294	200	200	212	192	165	75	70	63	52	53	53	50
EBITDA*	21,158,694	19,205,467	31,143,519	9,659,946	8,144,901	8,393,353	2,949,996	2,084,348	3,910,076	9,306,238	6,534,901	2,515,779	5,035,155	5,113,765	5,307,838

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	1,116,812	1,139,103	12,062			483,174	648,229	812,233	788,670	938,334	391,211	333,751	239,439	281,894	320,094
Intangible Assets	81,471
Investments & Other	686,751	686,751		56,757,682	56,757,682					1	1	4,758,901
Debtors (Due After 1 year)
Total Fixed Assets	1,885,034	1,825,854	12,062	56,757,682	56,757,682	483,174	648,229	812,233	788,670	938,335	391,212	5,092,652	239,439	281,894	320,094
Stock & work in progress	134,728,463	86,573,058	98,511,999	52,448,330	36,994,474	60,867,083	25,056,956	20,821,049	17,480,148	15,677,566	14,227,897	25,379,128	22,043,885	37,693,237	22,788,257
Trade Debtors	146,764,097	147,575,408	132,051,776	73,156,216	73,742,175	57,957,808	40,721,810	30,128,048	24,790,727	16,117,901	12,810,486	11,354,514	18,254,466	33,565,454	34,297,625
Group Debtors	7,811,045	79,130,840	42,132,236	20,310,881	42,145,415	41,339,397	21,983,912	4,194,004	22,244,215	12,704,231	46,206,430	38,481,836	10,268,731	6,554,625	5,972,188
Misc Debtors	35,799,769	5,389,481	8,603,839	7,248,813	2,944,905	2,068,043	2,612,802	2,925,339	2,014,882	1,674,154	3,386,053	5,100,405	3,677,106	6,620,153	2,194,400
Cash			11,038										30,524,994	32,342,968	29,984,934
misc current assets
total current assets	325,103,374	318,668,787	281,310,888	153,164,240	155,826,969	162,232,331	90,375,480	58,068,440	66,529,972	46,173,852	76,630,866	80,315,883	84,769,182	116,776,437	95,237,404
total assets	326,988,408	320,494,641	281,322,950	209,921,922	212,584,651	162,715,505	91,023,709	58,880,673	67,318,642	47,112,187	77,022,078	85,408,535	85,008,621	117,058,331	95,557,498
Bank overdraft
Bank loan
Trade Creditors	6,977,396	7,475,362	17,596,539	6,466,587	3,781,302	3,269,858	2,762,256	3,891,453	2,154,348	954,882	1,978,004	1,010,886	2,349,350	1,453,867	1,828,810
Group/Directors Accounts	93,063,242	6,175,235	32,111,243	18,231,470	48,185,376	75,462,459	33,530,326	9,700,361	21,273,280	7,226,024	5,398,708	19,218,070	19,152,021	52,681,726	40,268,815
other short term finances
hp & lease commitments
other current liabilities	61,211,852	157,246,286	100,226,217	73,322,506	56,427,006	42,788,176	19,989,627	12,597,229	12,983,600	10,352,904	7,477,147	4,602,889	11,859,382	14,789,355	13,968,907
total current liabilities	161,252,490	170,896,883	149,933,999	98,020,563	108,393,684	121,520,493	56,282,209	26,189,043	36,411,228	18,533,810	14,853,859	24,831,845	33,360,753	68,924,948	56,066,532
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions	812,928	763,468	1,118,373	610,700	684,986	846,712	1,006,428	1,164,558	1,396,509	1,946,956	2,455,688	2,308,812	100,000
total long term liabilities	812,928	763,468	1,118,373	610,700	684,986	846,712	1,006,428	1,164,558	1,396,509	1,946,956	2,455,688	2,308,812	100,000
total liabilities	162,065,418	171,660,351	151,052,372	98,631,263	109,078,670	122,367,205	57,288,637	27,353,601	37,807,737	20,480,766	17,309,547	27,140,657	33,460,753	68,924,948	56,066,532
net assets	164,922,990	148,834,290	130,270,578	111,290,659	103,505,981	40,348,300	33,735,072	31,527,072	29,510,905	26,631,421	59,712,531	58,267,878	51,547,868	48,133,383	39,490,966
total shareholders funds	164,922,990	148,834,290	130,270,578	111,290,659	103,505,981	40,348,300	33,735,072	31,527,072	29,510,905	26,631,421	59,712,531	58,267,878	51,547,868	48,133,383	39,490,966

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	20,640,251	18,967,995	31,126,329	9,659,946	8,014,174	8,217,046	2,747,297	1,890,504	3,716,615	9,100,854	6,365,901	2,401,581	4,922,525	5,005,301	5,172,646
Depreciation	494,222	237,472	17,190		130,727	176,307	202,699	193,844	193,461	205,384	169,000	114,198	112,630	108,464	135,192
Amortisation	24,221
Tax	-5,938,855	-1,704,399	-4,144,629	-1,909,624	-1,384,467	-1,412,716	-536,629	59,148	-778,628	-2,008,686	-1,378,509	-449,120	-1,720,577	3,427,659	140,130
Stock	48,155,405	-11,938,941	46,063,669	15,453,856	-23,872,609	35,810,127	4,235,907	3,340,901	1,802,582	1,449,669	-11,151,231	3,335,243	-15,649,352	14,904,980	22,788,257
Debtors	-41,720,818	49,307,878	82,071,941	-18,116,585	17,467,247	36,046,724	28,071,133	-11,802,433	18,553,538	-31,906,683	7,466,214	22,736,452	-14,539,929	4,276,019	42,464,213
Creditors	-497,966	-10,121,177	11,129,952	2,685,285	511,444	507,602	-1,129,197	1,737,105	1,199,466	-1,023,122	967,118	-1,338,464	895,483	-374,943	1,828,810
Accruals and Deferred Income	-96,034,434	57,020,069	26,903,711	16,895,500	13,638,830	22,798,549	7,392,398	-386,371	2,630,696	2,875,757	2,874,258	-7,256,493	-2,929,973	820,448	13,968,907
Deferred Taxes & Provisions	49,460	-354,905	507,673	-74,286	-161,726	-159,716	-158,130	-231,951	-550,447	-508,732	146,876	2,208,812	100,000
Cash flow from operations	-87,697,688	26,676,118	-62,595,384	29,919,550	27,154,344	-41,729,779	-23,788,602	11,723,811	-13,944,957	39,098,469	12,829,661	-30,391,181	31,569,369	-10,194,070	-44,006,785
Investing Activities
capital expenditure	-577,623	-1,364,513	-29,252		352,447	-11,252	-38,695	-217,407	-43,797	-752,507	-226,460	-208,510	-70,175	-70,264	-455,286
Change in Investments		686,751	-56,757,682		56,757,682				-1		-4,758,900	4,758,901
cash flow from investments	-577,623	-2,051,264	56,728,430		-56,405,235	-11,252	-38,695	-217,407	-43,796	-752,507	4,532,440	-4,967,411	-70,175	-70,264	-455,286
Financing Activities
Bank loans
Group/Directors Accounts	86,888,007	-25,936,008	13,879,773	-29,953,906	-27,277,083	41,932,133	23,829,965	-11,572,919	14,047,256	1,827,316	-13,819,362	66,049	-33,529,705	12,412,911	40,268,815
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue	-47,410	48,600	-6,257,313		56,757,682					-40,758,901		4,758,901			33,992,988
interest	1,434,714	1,251,516	-2,035,121	34,356	-229,708	-191,102	-29,790	19,245	18,301	71,626	15,473	37,970	374,928	287,463	198,664
cash flow from financing	88,275,311	-24,635,892	5,587,339	-29,919,550	29,250,891	41,741,031	23,800,175	-11,553,674	14,065,557	-38,859,959	-13,803,889	4,862,920	-33,154,777	12,700,374	74,460,467
cash and cash equivalents
cash		-11,038	11,038									-30,524,994	-1,817,974	2,358,034	29,984,934
overdraft
change in cash		-11,038	11,038									-30,524,994	-1,817,974	2,358,034	29,984,934

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for takeda uk limited. Get real-time insights into takeda uk limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for takeda uk limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mega companies, companies in W 2 area or any other competitors across 12 key performance metrics.

TAKEDA UK LIMITED group structure

Takeda Uk Limited has 2 subsidiary companies.

Ultimate parent company

TAKEDA PHARMACEUTICAL COMPANY LTD

#0052845

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

#0100703

2 parents

TAKEDA UK LIMITED

03362860

2 subsidiaries

SHIRE PHARMACEUTICAL CONTRACTS LIMITED

02024595

SHIRE PHARMACEUTICALS LIMITED

02031674

TAKEDA UK LIMITED Shareholders

takeda pharmaceuticals international ag

100%

Takeda Uk Limited currently has 4 directors. The longest serving directors include Mr Kentaro Shirahata (Jun 2019) and Mr Peter Grubin (Mar 2022).

officer	country	age	start	end	role
Mr Kentaro Shirahata	United Kingdom	49 years	Jun 2019	-	Director
Mr Peter Grubin		44 years	Mar 2022	-	Director
Ms Seyda Memis	United Kingdom	46 years	Aug 2022	-	Director
Dr Emma Roffe	United Kingdom	53 years	Dec 2022	-	Director

P&L

March 2024

turnover

516m

+7%

operating profit

20.6m

+9%

gross margin

21.9%

+33.4%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

164.9m

+0.11%

total assets

327m

+0.02%

cash

net assets

Total assets minus all liabilities

Similar Companies

ontex retail uk limited

goldsmith resources limited

rb (china trading) limited

4.5

napp pharmaceuticals limited

4.5

nupharm limited

company number

03362860

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

April 1997

ultimate parent company

TAKEDA PHARMACEUTICAL COMPANY LTD

previous names

N/A

address

1 kingdom street, london, W2 6BD

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to takeda uk limited. Currently there are 1 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for TAKEDA UK LIMITED. This can take several minutes, an email will notify you when this has completed.

takeda uk limited Company Information

takeda uk limited Estimated Valuation

takeda uk limited Estimated Valuation

takeda uk limited Estimated Valuation

Takeda Uk Limited Overview

Takeda Uk Limited Health Check

TAKEDA UK LIMITED financials

takeda uk limited Credit Report and Business Information

Takeda Uk Limited Competitor Analysis

takeda uk limited Ownership

takeda uk limited directors

takeda uk limited company details

takeda uk limited Charges & Mortgages

takeda uk limited Capital Raised & Share Issues BETA

takeda uk limited Companies House Filings - See Documents